Atara Biotherapeutics, Inc. (ATRA)

Atara Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13.84	25.03	25.84	92.94	106.08	200.4
Short-Term Investments	-	17.47	25.88	149.88	264.98	300.26
Cash & Short-Term Investments	13.84	42.5	51.73	242.82	371.07	500.66
Cash Growth	-70.07%	-17.84%	-78.70%	-34.56%	-25.88%	93.22%
Accounts Receivable	8.88	1.48	34.11	40.22	0.99	-
Other Receivables	-	-	-	0.8	0.8	1.95
Receivables	8.88	1.48	34.11	41.02	1.79	1.95
Inventory	-	10.66	9.71	1.59	-	-
Prepaid Expenses	-	-	-	-	-	20.47
Restricted Cash	0.15	0.15	0.15	0.15	0.19	0.19
Other Current Assets	4.32	10.12	6.18	9.51	11.57	-
Total Current Assets	27.18	64.89	101.87	295.08	384.62	523.27
Property, Plant & Equipment	32.01	41.1	58.79	74.32	79.94	62.82
Other Long-Term Assets	2.84	3.1	4.84	7.02	3.57	2.03
Total Assets	62.04	109.1	165.5	376.42	468.13	588.12
Accounts Payable	1.38	4.37	3.68	6.87	17.37	7.12
Accrued Expenses	16.61	21.2	48.53	50.41	44.91	40.34
Current Portion of Leases	13.92	13.92	12.18	13.64	2.75	1.99
Current Unearned Revenue	15.98	95.09	77.83	8	40.76	33.46
Total Current Liabilities	47.89	134.57	142.23	78.92	105.79	82.9
Long-Term Leases	28.03	31.52	45.69	58.06	25.52	13.04
Long-Term Unearned Revenue	39.38	38.62	72.19	107.24	55.71	27.8
Other Long-Term Liabilities	1.81	1.67	4.63	5.56	1.5	2.04
Total Liabilities	117.11	206.38	264.74	249.78	188.51	125.78
Common Stock	0	0	-	0.01	0.01	0.01
Additional Paid-In Capital	1,961	1,957	1,870	1,822	1,745	1,587
Retained Earnings	-2,017	-2,055	-1,969	-1,693	-1,465	-1,125
Comprehensive Income & Other	-	0.01	-0.2	-2.07	-0.37	0.3
Shareholders' Equity	-55.07	-97.28	-99.23	126.64	279.61	462.34
Total Liabilities & Equity	62.04	109.1	165.5	376.42	468.13	588.12
Total Debt	41.94	45.43	57.87	71.7	28.27	15.03
Net Cash (Debt)	-28.1	-2.94	-6.15	171.12	342.8	485.63
Net Cash Growth	-	-	-	-50.08%	-29.41%	99.53%
Net Cash Per Share	-3.20	-0.39	-1.45	41.94	91.49	164.13
Filing Date Shares Outstanding	5.96	5.86	4.77	3.84	3.72	3.34
Total Common Shares Outstanding	5.92	5.86	4.26	3.84	3.67	3.33
Working Capital	-20.71	-69.68	-40.36	216.16	278.84	440.37
Book Value Per Share	-9.30	-16.60	-23.31	33.00	76.25	138.64
Tangible Book Value	-55.07	-97.28	-99.23	126.64	279.61	462.34
Tangible Book Value Per Share	-9.30	-16.60	-23.31	33.00	76.25	138.64
Machinery	1.91	17.67	18.66	17.82	26.05	19.18
Construction In Progress	-	-	0.16	0.03	6.33	0.88
Leasehold Improvements	0.07	0.93	0.9	0.88	50.14	50.13

Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q